Wei-Ting Hwang

27PUBLICATIONS
236CO-AUTHORS
Human impacts of climate change and human adaptationRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 09, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.

Beatrice M Razzo, Shonali Midha, Andrew J Portuguese

|Jun 01, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.

Stephen J Bagley, Arati S Desai, Joseph A Fraietta

|Jan 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Julie K Jadlowsky, Elizabeth O Hexner, Amy Marshall

|Dec 10, 2024
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis.

Peter A Riedell, Connor B Grady, Loretta J Nastoupil

|Sep 27, 2024
Cytokine-mediated CAR T therapy resistance in AML.

Anand S Bhagwat, Leonel Torres, Olga Shestova

Pageof 5